Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Clinical trial NCT02446132 · TERMINATED
Trial details
- NCT number
- NCT02446132
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-13
- Primary completion
- 2024-09-06
- Enrollment
- 1197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.